HealthInvestor Executive Moves
Remember me:
HealthInvestor Executive moves The latest appointments in the independent healthcare industry

Advanced Oncotherapy: Gabriel Urwitz, Peter Sjöstrand, Chunlin “Allen” Han and Yuelong Huang

Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, has announced the following changes to its Board of Directors.

Mr Gabriel Urwitz, Mr Peter Sjöstrand, Mr Chunlin “Allen” Han,  and Dr Yuelong Huang (all Non-Executive Directors of the Company), will step down from the Board and not seek re-election at the Company’s upcoming Annual General Meeting which is expected to be held in July 2020. Once these Board changes become effective in July 2020, the Board will decrease from 12 members to eight members and will comprise of three executive directors and five non-executive directors.

The audited results for the year ended 31 December 2019 are expected to be announced on or around 29 June 2020. The annual report and accounts will be published shortly thereafter and posted to shareholders together with the notice of AGM.

Dr Mike Sinclair, executive chairman of Advanced Oncotherapy, commented: “On behalf of the Board, I would like to thank Gabriel, Peter, Allen and Yuelong for their strategic counsel and insight to Advanced Oncotherapy over the years. As valued Board members, they have helped Advanced Oncotherapy to progress to a leading position as a technology disruptor in proton therapy, and we wish them all the best in their future endeavours.

Posted on: 01/07/2020

Latest news stories

Aedifica has agreed a sale and leaseback with luxury care home developer Hamberley Development, for the newly completed Richmond Manor Care Home, in Ampthill, Bedfordshire.
Latest figures from real estate advisor CBRE show that UK care home rent collection was 96.8% in June, despite the sector being on the front line of the Covid-19 pandemic.
NHSX has awarded smart health informatics provider Alcidion a place on the Clinical Communications Procurement Framework, a new procurement vehicle intended to help the NHS phase out pagers.
Uvence, a company set up by cosmetic surgeon Dr Olivier Amar and Reece Tomlinson, plans to disrupt the non-surgical cosmetic treatment market and is preparing for a raise next month.
Insurer-funded healthcare reached 58% of 2019 activity levels in July, compared with 47% in June and 29% in May.

HealthInvestor Feature

Consultant profile

Introducing: Sam Leighton-Smith

As the founding director of Compass Executives, Sam has unprecedented industry knowledge which has seen him become one of the go-to executive search consultants within the independent health, social care and education sectors.

Sam primarily works C-suite level assignments, with a significant track record completing mandates for UK, European and international investors.

Recently completed mandates:

  • CEO | elderly care | international investors
  • Chair | children’s services | international investors
  • CEO designate | supported living | UK PE
  • NED | adult social care | UK PE
  • CEO | fostering | UK PE
Compass Executives
To find out more about Sam, or to contact him about new opportunities, please contact or call 02392 384 555.

2019 InvestorPublishing.